2019 Advisory Board

Erik Folch, MD, MSc

Erik Folch

Dr. Folch was born and raised in Mexico City. He received his medical degree from Universidad Nacional Autonoma de Mexico, and Masters of Science in Clinical Research from Emory University. He trained in Internal Medicine at Emory University, and Pulmonary, Critical Care, Interventional Pulmonary at Cleveland Clinic. He is currently the Chief of the Complex…

Read More

Jan De Backer, MSc, PhD, MBA

Jan DeBacker

Dr. De Backer graduated from Delft University of Technology, The Netherlands as aerospace engineer. He attained an MSc degree in aerodynamics and specialized in applied biomedical computational fluid dynamics leading to a PhD from the University of Antwerp, Belgium. He is an alumnus of the MBA programs at London Business School, London and Columbia Business…

Read More

Mark Gelfand

Mark Gelfand

Mr. Gelfand has more than 25 years of experience innovating medical devices in academic, startup and corporate environments. With Dr. Levin, he co-founded 10 venture-funded startups and served as the CTO to those ventures. Prior to becoming an entrepreneur, Mr. Gelfand worked at Nellcor Puritan Bennett, the world’s leading respiratory device company, where he was…

Read More

Cayce Denton

Cayce Denton is a member of the healthcare investment team at Temasek, where she covers US therapeutics investing for both private and public companies. Private healthcare investments she has led at Temasek include Aerogen, Locana and Viela Bio. Previously, Cayce was in biotech venture capital at TPG Biotech, in operating roles at Genentech and Novartis,…

Read More

Milica Vukmirovic, PhD

Milica Vukmirovic

Milica Vukmirovic, PhD, holds the position of Blavatnik Fellow in Life Science Entrepreneurship at the Office of Cooperative Research (OCR) and Blavatnik Innovation Fund at Yale University. She works on commercialization of medical breakthrough innovations across Yale and assists Blavatnik Innovation Fund activities. She recently was elected as the Chair of the newly formed ATS…

Read More

Lonny Yarmus, DO, MBA FCCP, ATSF

Lonny Yarmus

Lonny Yarmus, DO, MBA FCCP, ATSF, is an Associate Professor of Medicine and Oncology and Clinical Chief of the Division of Pulmonary and Critical Care Medicine at Johns Hopkins University School of Medicine. He also serves as the Director of the Center for Interventional Pulmonary Research at Johns Hopkins University. Dr. Yarmus is an interventional…

Read More

Jason Pesterfield

Jason Pesterfield

Jason has been in the Med-Tech space for 25 years with the majority of his career spent leading efforts around the development and commercialization of cutting edge technologies such as surgical power tools, navigation and robotics. At Veran, Jason and his team’s mission is to enable thoracic and interventional specialists to diagnose soft tissue cancers…

Read More

C. Matthew Kinsey, MD, MPH

C. Matthew Kinsey

Dr. Kinsey directs the Interventional Pulmonary Program at the University of Vermont Medical Center. This program focuses on advanced diagnostic and therapeutic procedures to address thoracic diseases, and includes endobronchial valve placement for advanced emphysema, intraoperative cone beam navigational bronchoscopy, holmium and Nd:YAG laser therapy, airway stenting, and direct tumoral therapies (Endobronchial Ultrasound-Guided Transbronchial Needle…

Read More

Wade Lange

Wade Lange

With diverse experience in the life sciences industry, Wade Lange’s background encompasses broad experience in the areas of biotechnology entrepreneurship, clinical research, marketing, marketing research, business development and general management in the pharmaceutical, medical device and healthcare sectors. As president & CEO of ImmuneWorks he led the company from formation through completion of its Phase…

Read More

Jonathan Waldstreicher, MD, MBA

Jonathan Waldstreicher

Jonathan Waldstreicher, Principal, joined Apple Tree Partners in 2013 to invest in medical devices. After incubating an interventional pulmonary technology for two years, Jon founded Gala Therapeutics in Silicon Valley and assumed the CEO role to further its development. Prior to joining ATP, Jon was a Director, Global Surgery R&D, at Johnson & Johnson where…

Read More